BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 10703127)

  • 1. Six-month results of hyperopic and astigmatic LASIK in eyes with primary and secondary hyperopia.
    Lindstrom RL; Hardten DR; Houtman DM; Witte B; Preschel N; Chu YR; Samuelson TW; Linebarger EJ
    Trans Am Ophthalmol Soc; 1999; 97():241-55; discussion 255-60. PubMed ID: 10703127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early results of hyperopic and astigmatic laser in situ keratomileusis in eyes with secondary hyperopia.
    Lindstrom RL; Linebarger EJ; Hardten DR; Houtman DM; Samuelson TW
    Ophthalmology; 2000 Oct; 107(10):1858-63; discussion 1863. PubMed ID: 11013186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wavefront-guided laser in situ keratomileusis retreatment for consecutive hyperopia and compound hyperopic astigmatism.
    Bababeygy SR; Zoumalan CI; Chien FY; Manche EE
    J Cataract Refract Surg; 2008 Aug; 34(8):1260-6. PubMed ID: 18655974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperopic laser in situ keratomileusis in eyes with previous radial keratotomy.
    Oral D; Awwad ST; Seward MS; Bowman RW; McCulley JP; Cavanagh HD
    J Cataract Refract Surg; 2005 Aug; 31(8):1561-8. PubMed ID: 16129292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser vision correction for low hyperopia. An 18-month assessment of safety and efficacy.
    Jackson WB; Casson E; Hodge WG; Mintsioulis G; Agapitos PJ
    Ophthalmology; 1998 Sep; 105(9):1727-38; discussion 1737-8. PubMed ID: 9754184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CustomVue laser in situ keratomileusis for myopia and myopic astigmatism using the Visx S4 excimer laser: Efficacy, predictability, and safety.
    Partal AE; Manche EE
    J Cataract Refract Surg; 2006 Mar; 32(3):475-9. PubMed ID: 16631061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Femtosecond laser in situ keratomileusis for consecutive hyperopia after radial keratotomy.
    Muñoz G; Albarrán-Diego C; Sakla HF; Javaloy J
    J Cataract Refract Surg; 2007 Jul; 33(7):1183-9. PubMed ID: 17586373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser in situ keratomileusis for primary hyperopia.
    Jin GJ; Lyle WA; Merkley KH
    J Cataract Refract Surg; 2005 Apr; 31(4):776-84. PubMed ID: 15899456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperopic laser-assisted in situ keratomileusis results with LADARVision, Visx Star S2, and Visx Star S3.
    Oral D; Bowman RW; Cavanagh HD; El-Agha MS; Seward MS; McCulley JP
    Eye Contact Lens; 2004 Jan; 30(1):49-53. PubMed ID: 14722471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser in situ keratomileusis for the correction of residual ametropia after penetrating keratoplasty.
    Buzard K; Febbraro JL; Fundingsland BR
    J Cataract Refract Surg; 2004 May; 30(5):1006-13. PubMed ID: 15130636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wavefront-guided retreatment after primary wavefront-guided laser in situ keratomileusis in myopes and hyperopes: long-term follow-up.
    Kashani S; Rajan M; Gartry D
    Am J Ophthalmol; 2009 Mar; 147(3):417-423.e2. PubMed ID: 19054497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of hyperopic laser in situ keratomileusis correction using the Star S2 excimer laser.
    Desai RU; Jain A; Manche EE
    J Cataract Refract Surg; 2008 Feb; 34(2):232-7. PubMed ID: 18242445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved safety in contemporary LASIK.
    Watson SL; Bunce C; Allan BD
    Ophthalmology; 2005 Aug; 112(8):1375-80. PubMed ID: 15953643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term analysis of LASIK for the correction of refractive errors after penetrating keratoplasty.
    Hardten DR; Chittcharus A; Lindstrom RL
    Trans Am Ophthalmol Soc; 2002; 100():143-50; discussion 150-2. PubMed ID: 12545688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excimer laser treatment of spherical hyperopia: PRK or LASIK?
    el-Agha MS; Johnston EW; Bowman RW; Cavanagh HD; McCulley JP
    Trans Am Ophthalmol Soc; 2000; 98():59-66; discussion 66-9. PubMed ID: 11190041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic and biomechanical differences between hyperopic and myopic laser in situ keratomileusis.
    Qazi MA; Roberts CJ; Mahmoud AM; Pepose JS
    J Cataract Refract Surg; 2005 Jan; 31(1):48-60. PubMed ID: 15721696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser in situ keratomileusis for primary and secondary mixed astigmatism.
    Jin GJ; Merkley KH; Lyle WA
    Am J Ophthalmol; 2005 Jun; 139(6):1019-27. PubMed ID: 15953431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal aberrations and objective visual quality after hyperopic laser in situ keratomileusis using the Esiris excimer laser.
    Alió JL; Piñero DP; Espinosa MJ; Corral MJ
    J Cataract Refract Surg; 2008 Mar; 34(3):398-406. PubMed ID: 18299063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LASIK in the presbyopic age group: safety, efficacy, and predictability in 40- to 69-year-old patients.
    Ghanem RC; de la Cruz J; Tobaigy FM; Ang LP; Azar DT
    Ophthalmology; 2007 Jul; 114(7):1303-10. PubMed ID: 17382397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperopic laser in situ keratomileusis: primary and secondary treatments are safe and effective.
    Choi RY; Wilson SE
    Cornea; 2001 May; 20(4):388-93. PubMed ID: 11333326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.